Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $13.8900 (-6.4%) ($13.7400 - $13.8900) on Wed. Jan. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.49% (three month average) | RSI | 27 | Latest Price | $13.8900(-6.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.6% a day on average for past five trading days. | Weekly Trend | TGTX declines -10% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(75%) ARKG(69%) IBB(67%) ARKK(64%) IWO(62%) | Factors Impacting TGTX price | TGTX will decline at least -3.245% in a week (0% probabilities). VIXM(-48%) VXX(-39%) UUP(-28%) UNG(-6%) USO(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.245% (StdDev 6.49%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.75(-162.99%) | Resistance Level | $16.41 | 5 Day Moving Average | $14.15(-1.84%) | 10 Day Moving Average | $14.57(-4.67%) | 20 Day Moving Average | $16.41(-15.36%) | To recent high | -61% | To recent low | 2.1% | Market Cap | $1.759b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |